Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get full text access Log in, subscribe or purchase for full access. References 1. Garvey, WT ∙ Mechanick, JI ∙ Brett, EM ∙ et al., the Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity Endocr Pract. 2016; 22:1-203 2. Ruze, R ∙ Liu, T ∙ Zou, X ∙ et al.
Introduction Obesity contributes to the development and progression of type 2 diabetes, while also increasing the risk of dyslipidaemia, hypertension, and cardiovascular disease.1,2 GLP-1 receptor agonists have shown efficacy in lowering HbA1c and reducing bodyweight in adults with type 2 diabetes.2–4 In many countries, including the USA and EU countries, once-weekly subcutaneous semaglutide 2·4 mg is approved for bodyweight management in adults with obesity or with overweight in the presence...
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
